The aim of this study was to examine possible discriminant physical and physiological characteristics between elite male handball players from elite teams with different league rankings. Players from three teams (A, B and C), which competed in the first league of the Greek championship during the season 2011-2012 participated in the study. Team A finished first, B came second and C came eighth out of eleven clubs. Teams A and B also participated in European Cups, and team A won the European Challenge Cup. The players (n=44) were examined for anthropometric characteristics and performed a series of physical fitness tests. Players from teams A and B were taller (6.2 cm (0.7;11.7), mean difference (95% CI) and 9.2 cm (4.0;14.5), respectively), and had a higher amount of fat free mass (6.4 kg (1.1;11.8) and 5.4 kg (0.2;10.5)) compared to those of team C. Players from team A performed better than players from team C in the squat jump (5.5 cm (1.0;10.0)), the countermovement jump without (5.5 cm (0.4;10.6)) and with arm-swing (6.0 cm (0.7;11.3)) and in the 30 s Bosco test (5.7 W·kg-1 (1.2;10.2)). Also, players from team A outperformed team B in mean power during the Wingate anaerobic test (WAnT, 0.5 W·kg-1(0;0.9)) and in the Bosco test (7.8 W·kg-1 (3.4;12.2)). Overall, players from the best ranked team performed better than the lowest ranked team on WAnT, vertical jumps and the Bosco test. Stepwise discriminant analysis showed that stature and mean power during the Bosco test were the most important characteristics in TH players, accounting for 54.6% of the variance in team ranking. These findings indicate the contribution of particular physical fitness components (stature, fat free mass and anaerobic power) to excellence in TH. In addition, the use of the Bosco test as an assessment tool in talent identification and physical fitness monitoring in this sport is further recommended.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827752 | PMC |
http://dx.doi.org/10.2478/hukin-2013-0051 | DOI Listing |
Int J Infect Dis
January 2025
END Fund, New York, USA. Electronic address:
Objectives: Schistosomiasis (SCH) remains a public health challenge in Rwanda despite ongoing interventions. This paper provides an overview of Rwanda's SCH journey, highlighting progress made through mass drug administration (MDA), diagnostic advancements, and strategic partnerships with key stakeholders.
Methods: Since 2014, the point-of-care circulating cathodic antigen (POC-CCA) test has been introduced alongside Kato-Katz (KK), improving mapping accuracy and detecting low-intensity infections.
JMIR Aging
January 2025
Luddy School of Informatics, Computing, and Engineering, Indiana University, Bloomington, IN, United States.
Background: Many members of Black American communities, faced with the high prevalence of Alzheimer disease and related dementias (ADRD) within their demographic, find themselves taking on the role of informal caregivers. Despite being the primary individuals responsible for the care of individuals with ADRD, these caregivers often lack sufficient knowledge about ADRD-related health literacy and feel ill-prepared for their caregiving responsibilities. Generative AI has become a new promising technological innovation in the health care domain, particularly for improving health literacy; however, some generative AI developments might lead to increased bias and potential harm toward Black American communities.
View Article and Find Full Text PDFEuroIntervention
January 2025
Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
Background: Few data are available on polymer-free drug-eluting stents in patients undergoing percutaneous coronary intervention (PCI).
Aims: We aimed to determine the efficacy and safety of a polymer-free amphilimus-eluting stent (AES), using a reservoir-based technology for drug delivery, compared with a biodegradable-polymer everolimus-eluting stent (EES).
Methods: This was a randomised, investigator-initiated, assessor-blind, non-inferiority trial conducted at 14 hospitals in Italy (ClinicalTrials.
Healthcare (Basel)
December 2024
Department of Clinical and Experimental Medicine, University of Catanzaro MagnaGraecia, 88100 Catanzaro, Italy.
Background: Inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, is a heterogeneous chronic condition characterized by periods of relapse and remission. Ulcerative colitis involves inflammation of the colon and rectum mucosa, while Crohn's disease causes deeper, transmural inflammation affecting all four gut layers from the mouth to the anus and can lead to complications such as fistulation. IBD significantly impacts patients' physical and psychological well-being, thus reducing their quality of life (QoL).
View Article and Find Full Text PDFLung Cancer
December 2024
Università Vita-Salute San Raffaele, Milan, Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Background: Artificial intelligence (AI) models are emerging as promising tools to identify predictive features among data coming from health records. Their application in clinical routine is still challenging, due to technical limits and to explainability issues in this specific setting. Response to standard first-line immunotherapy (ICI) in metastatic Non-Small-Cell Lung Cancer (NSCLC) is an interesting population for machine learning (ML), since up to 30% of patients do not benefit.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!